Vasodilators: New Insights
A special issue of Pathophysiology (ISSN 1873-149X).
Deadline for manuscript submissions: closed (31 December 2022) | Viewed by 3440
Interests: nitric oxide; polyphenolic compounds; cardiovascular system; hypertension; metabolic syndrome
Special Issues, Collections and Topics in MDPI journals
Vasodilators have been known for 120 years and yet our knowledge of them is still insufficient for successfully treating cardiovascular diseases, hypertension, angina pectoris, metabolic syndrome and other diseases requiring improved vasodilation. We, therefore, invite you to publish your latest results on the molecular nature, mechanisms, modifiability, effects and therapeutic possibilities of endogenous vasodilators, as well as the drugs that belong to them. Our Special Issue is mainly devoted to original knowledge in the field of c-AMP-, c-GMP- and hyperpolarization-mediated vasodilation, and PDE5 inhibitors and potassium channel openers, to central vasomotor control mechanisms, cold-induced vasodilation and other mechanisms of vasodilation. The Special Issue further focuses on modifiers of vasodilatory mechanisms, such as polyphenolic substances and many antioxidants; the targeted delivery of vasodilators, e.g., through nanoparticles; potential new vasodilators; and new perspectives on treatment options. Within this Special Issue, original articles, experimental results, clinical studies and more-extensive reviews will be published. We look forward to your contributions and cooperation.
Dr. Olga Pecháňová
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pathophysiology is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- cardiovascular diseases
- blood pressure
- nitric oxide
- polyphenolic substances